Financial Avengers’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-729
Closed -$91.3K 151
2025
Q4
$91.3K Buy
729
+4
+0.6% +$510 0.04% 44
2025
Q3
$97.1K Buy
725
+3
+0.4% +$394 0.04% 46
2025
Q2
$98.2K Buy
722
+3
+0.4% +$396 0.05% 46
2025
Q1
$95.4K Buy
719
+3
+0.4% +$382 0.05% 45
2024
Q4
$80.9K Sell
716
-116
-14% -$13.4K 0.04% 53
2024
Q3
$94.9K Buy
832
+3
+0.4% +$329 0.05% 49
2024
Q2
$86.1K Buy
829
+124
+18% +$13.1K 0.05% 46
2024
Q1
$79K Sell
705
-230
-25% -$26.4K 0.04% 50
2023
Q4
$103K Buy
935
+5
+0.5% +$500 0.06% 41
2023
Q3
$90K Buy
930
+5
+0.5% +$525 0.06% 45
2023
Q2
$101K Buy
925
+4
+0.4% +$426 0.07% 42
2023
Q1
$93.3K Buy
921
+4
+0.4% +$422 0.07% 40
2022
Q4
$101K Buy
917
+5
+0.5% +$518 0.08% 36
2022
Q3
$88K Buy
912
+3
+0.3% +$320 0.07% 39
2022
Q2
$99K Sell
909
-81
-8% -$9.2K 0.08% 37
2022
Q1
$117K Sell
990
-190
-16% -$23.6K 0.07% 39
2021
Q4
$166K Buy
1,180
+4
+0.3% +$512 0.1% 34
2021
Q3
$139K Sell
1,176
-495
-30% -$60.8K 0.09% 38
2021
Q2
$194K Buy
1,671
+6
+0.4% +$699 0.13% 29
2021
Q1
$200K Buy
1,665
+615
+59% +$72.9K 0.15% 25
2020
Q4
$115K Buy
+1,050
New +$114K 0.09% 31

Other funds holding ABT

Financial Avengers's ABT Position: Q1 2026 in Review

Financial Avengers sold out of Abbott (ABT) in Q1 2026, closing a stake of 729 shares — an estimated $91.3K sold.

Financial Avengers first reported a position in ABT in Q4 2020 and held it in 21 quarters. The position peaked at $200K in Q1 2021. 3,090 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Financial Avengers reported no remaining Abbott position as of Q1 2026 after selling out during the quarter.
  • Financial Avengers sold 729 Abbott shares in Q1 2026, an estimated $91.3K.
  • Financial Avengers first reported a position in Abbott in Q4 2020 and held it in 21 quarters.
  • Financial Avengers's Abbott position peaked at $200K in Q1 2021.
  • 3,090 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Financial Avengers's 13F filing for Q1 2026, filed 19 May 2026.